Frances E Carr

Publication Activity (10 Years)

Years Active: 2019-2023
Publications (10 Years): 7

Top Topics

Endoplasmic Reticulum Stress

Signaling Pathway

Sentinel Lymph Node

Breast Cancer Cells

Top Venues

Molecular cancer research : MCR

Molecular carcinogenesis

Hormones & cancer

This page only lists publications with an associated author ORCID identifier.

Publications

Noelle E Gillis, Lauren M Cozzens, Emily R Wilson, Noah M Smith, Jennifer A Tomczak, Eric L Bolf, Frances E Carr
TRβ Agonism Induces Tumor Suppression and Enhances Drug Efficacy in Anaplastic Thyroid Cancer in Female Mice. Endocrinology (2023)
Cole D Davidson, Jennifer A Tomczak, Eyal Amiel, Frances E Carr
Inhibition of Glycogen Metabolism Induces Reactive Oxygen Species-Dependent Cytotoxicity in Anaplastic Thyroid Cancer in Female Mice. Endocrinology 163 (12) (2022)
Noelle E Gillis, Joseph R Boyd, Jennifer A Tomczak, Seth E Frietze, Frances E Carr
Thyroid hormone dependent transcriptional programming by TRβ requires SWI/SNF chromatin remodelers. Nucleic acids research 50 (3) (2022)
Cole D Davidson, Eric L Bolf, Noelle E Gillis, Lauren M Cozzens, Jennifer A Tomczak, Frances E Carr
Thyroid Hormone Receptor Beta Inhibits PI3K-Akt-mTOR Signaling Axis in Anaplastic Thyroid Cancer via Genomic Mechanisms. Journal of the Endocrine Society 5 (8) (2021)
Eric L Bolf, Noelle E Gillis, Cole D Davidson, Lauren M Cozzens, Sophie Kogut, Jennifer A Tomczak, Seth Frietze, Frances E Carr
Common tumor-suppressive signaling of thyroid hormone receptor beta in breast and thyroid cancer cells. Molecular carcinogenesis 60 (12) (2021)
Eric L Bolf, Noelle E Gillis, Cole D Davidson, Princess D Rodriguez, Lauren Cozzens, Jennifer A Tomczak, Seth Frietze, Frances E Carr
Thyroid Hormone Receptor Beta Induces a Tumor-Suppressive Program in Anaplastic Thyroid Cancer. Molecular cancer research : MCR 18 (10) (2020)
Eric L Bolf, Noelle E Gillis, Michael S Barnum, Caitlin M Beaudet, Grace Y Yu, Jennifer A Tomczak, Janet L Stein, Jane B Lian, Gary S Stein, Frances E Carr
The Thyroid Hormone Receptor-RUNX2 Axis: A Novel Tumor Suppressive Pathway in Breast Cancer. Hormones & cancer 11 (1) (2019)